跳至主要内容
临床试验/NCT02137590
NCT02137590已完成1 期

An Open Label Pilot Study to Evaluate the Efficacy of Spanish Black Radish on the Induction of Phase I and Phase II Enzymes in Healthy Male Subjects

KGK Science Inc.2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Effect on Phase I and II enzymes

研究概览

简要总结

This study will investigate the effect of Spanish Black Radish on phase I and phase II enzyme activity in healthy adult males. The primary objective is to determine the effect on phase I and phase II enzyme activity by measuring plasma and urine acetaminophen metabolite concentrations prior to and after a 28 day supplementation period with Spanish black radish product.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male age 25 - 35 years
  • BMI 18 - 25 kg/m2
  • Healthy as determined by laboratory results, medical history
  • Agrees to avoid the consumption of cruciferous vegetables for 14 days prior to baseline and during the study treatment period
  • Has given voluntary, written, informed consent to participate in the study

排除标准

  • Chronic diseases or any medical conditions
  • Gall bladder disorders and /or bowel obstruction
  • Use of prescribed or over the counter medications for the treatment of any acute or chronic conditions
  • Use of muscle building steroids or body building aids
  • Use of products containing ingredients derived from the Cruciferae (Brassicaracea) plant family within 14 days prior to randomization
  • Use of natural health products other than vitamins or minerals within 14 days prior to randomization
  • Any clinically significant abnormal laboratory value. Meaning a disease process, an exacerbation or worsening of an existing condition, requires further or more frequent monitoring or requires further action(s) to be taken. Clinical significance can only be determined by the Qualified Investigator.
  • Participation in a clinical research trial within 30 days prior to randomization
  • Allergy or sensitivity to test product ingredients, Cruciferae/Brassicaracea plant family (includes mustard, cabbage, radish), acetaminophen or foods and beverages provided during the study
  • Individuals who are cognitively impaired and/or who are unable to give informed consent
  • Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject
  • Cannot take acetaminophen within 48 hrs of the baseline appointment or final 4-wk appointment.

结局指标

主要结局

Effect on Phase I and II enzymes

时间窗: 4 weeks

The effect on phase I and phase II enzyme activity determined by measuring plasma and urine acetaminophen metabolite concentrations Subjects will ingest 1000 mg of acetaminophen. Blood will be collected at 0, 2, 4, 6 and 8 hours after acetaminophen dosage for the analysis of plasma acetaminophen metabolites. These measurements will be performed prior to and after 4 weeks of treatment with Spanish Black Radish product.

次要结局

  • Assessment of Hormone Levels(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
1 期
Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)Familial Adenomatous Polyposis
NCT00770991The Cleveland Clinic34
已完成
1 期
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal CancerStage 0 Laryngeal CancerStage 0 Lip and Oral Cavity CancerStage 0 Nasopharyngeal CancerStage 0 Oropharyngeal CancerStage 0 Paranasal Sinus and Nasal Cavity CancerStage I Salivary Gland CancerStage I Squamous Cell Carcinoma of the HypopharynxStage I Squamous Cell Carcinoma of the LarynxStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Squamous Cell Carcinoma of the NasopharynxStage I Squamous Cell Carcinoma of the OropharynxStage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage I Verrucous Carcinoma of the LarynxStage I Verrucous Carcinoma of the Oral CavityStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the HypopharynxStage II Squamous Cell Carcinoma of the LarynxStage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the NasopharynxStage II Squamous Cell Carcinoma of the OropharynxStage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityStage II Verrucous Carcinoma of the LarynxStage II Verrucous Carcinoma of the Oral CavityStage III Salivary Gland CancerStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the NasopharynxStage III Squamous Cell Carcinoma of the OropharynxStage III Verrucous Carcinoma of the LarynxStage III Verrucous Carcinoma of the Oral CavityStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the NasopharynxStage IVA Salivary Gland CancerStage IVA Squamous Cell Carcinoma of the LarynxStage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Squamous Cell Carcinoma of the OropharynxStage IVA Nasal Cavity and Paranasal Sinus CancerStage IVA Verrucous Carcinoma of the LarynxStage IVA Verrucous Carcinoma of the Oral CavityStage IVB Salivary Gland CancerStage IVB Squamous Cell Carcinoma of the LarynxStage IVB Squamous Cell Carcinoma of the Lip and Oral CavityStage IVB Squamous Cell Carcinoma of the OropharynxStage IVB Oral Cavity Squamous Cell CarcinomaStage IVB Verrucous Carcinoma of the LarynxStage IVB Verrucous Carcinoma of the Oral CavityStage IVC Salivary Gland CancerStage IVC Squamous Cell Carcinoma of the LarynxStage IVC Oral Cavity Squamous Cell CarcinomaStage IVC Squamous Cell Carcinoma of the OropharynxParanasal Sinus and Nasal Cavity Squamous Cell CarcinomaStage IVC Verrucous Carcinoma of the LarynxStage IVC Verrucous Carcinoma of the Oral CavityTongue Cancer
NCT01469429Ohio State University Comprehensive Cancer Center70
已完成
2 期
Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected AdultsHIVEndothelial DysfunctionInflammationInsulin Resistance
NCT01046682University Hospitals Cleveland Medical Center40
已完成
不适用
Rice Intervention in Chronic Health StudyDiabetes Mellitus, Type 2
NCT06560541Taylor's University204
已完成
不适用
Prevention of Oral DNA Damage by Black RaspberriesSmokingDNA DamageOxidative StressOral Cancer
NCT04372914Milton S. Hershey Medical Center69
An Open Label Pilot Study to Evaluate the Efficacy... | 临床试验